Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.79)
# 529
Out of 4,429 analysts
379
Total ratings
49.7%
Success rate
21.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics | Maintained: Buy | $49 | $15.67 | +212.70% | 22 | Jun 16, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintained: Buy | $143 → $151 | $96.79 | +56.01% | 29 | Jun 16, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $79 | $27.44 | +187.90% | 23 | Jun 10, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $8 | $0.8583 | +832.08% | 16 | Jun 5, 2026 | |
| BBIO BridgeBio Pharma | Initiated Coverage: Buy | $104 | $66.27 | +56.93% | 1 | Jun 3, 2026 | |
| OCGN Ocugen | Maintained: Buy | $12 → $11 | $1.24 | +787.10% | 5 | May 27, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $116 → $111 | $54.69 | +102.96% | 20 | May 22, 2026 | |
| PVLA Palvella Therapeutics | Maintained: Buy | $227 | $113.10 | +100.71% | 19 | May 21, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $75 | $34.14 | +119.68% | 5 | May 21, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $43 | $6.16 | +598.05% | 15 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.7306 | +584.37% | 24 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 | $31.53 | +470.88% | 4 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $7.53 | +178.88% | 28 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $12.87 | +187.41% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.35 | +198.51% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $6.42 | +164.80% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $441 → $436 | $451.63 | -3.46% | 37 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $429 | $278.09 | +54.27% | 34 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $5.59 | +311.45% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $114 | $348.06 | n/a | 5 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $17.53 | n/a | 2 | Sep 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $123.76 | n/a | 4 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $98.22 | n/a | 1 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $46.29 | n/a | 4 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $27 | $107.13 | n/a | 2 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 | $0.1745 | n/a | 5 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.69 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $54.09 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $30.03 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $16 | $9.02 | n/a | 5 | May 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.15 | n/a | 2 | Jan 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.94 | n/a | 1 | May 13, 2014 |
Intellia Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $49
Current: $15.67
Upside: +212.70%
Rhythm Pharmaceuticals
Jun 16, 2026
Maintained: Buy
Price Target: $143 → $151
Current: $96.79
Upside: +56.01%
Ultragenyx Pharmaceutical
Jun 10, 2026
Maintained: Buy
Price Target: $79
Current: $27.44
Upside: +187.90%
Fractyl Health
Jun 5, 2026
Reiterated: Buy
Price Target: $8
Current: $0.8583
Upside: +832.08%
BridgeBio Pharma
Jun 3, 2026
Initiated Coverage: Buy
Price Target: $104
Current: $66.27
Upside: +56.93%
Ocugen
May 27, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $1.24
Upside: +787.10%
BioMarin Pharmaceutical
May 22, 2026
Maintained: Buy
Price Target: $116 → $111
Current: $54.69
Upside: +102.96%
Palvella Therapeutics
May 21, 2026
Maintained: Buy
Price Target: $227
Current: $113.10
Upside: +100.71%
Beam Therapeutics
May 21, 2026
Maintained: Buy
Price Target: $75
Current: $34.14
Upside: +119.68%
Wave Life Sciences
May 19, 2026
Maintained: Buy
Price Target: $43
Current: $6.16
Upside: +598.05%
May 18, 2026
Maintained: Buy
Price Target: $5
Current: $0.7306
Upside: +584.37%
May 12, 2026
Maintained: Buy
Price Target: $180
Current: $31.53
Upside: +470.88%
May 8, 2026
Maintained: Buy
Price Target: $21
Current: $7.53
Upside: +178.88%
May 8, 2026
Maintained: Buy
Price Target: $37
Current: $12.87
Upside: +187.41%
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $3.35
Upside: +198.51%
May 6, 2026
Maintained: Buy
Price Target: $17
Current: $6.42
Upside: +164.80%
May 5, 2026
Maintained: Hold
Price Target: $441 → $436
Current: $451.63
Upside: -3.46%
May 4, 2026
Maintained: Buy
Price Target: $429
Current: $278.09
Upside: +54.27%
Apr 21, 2026
Maintained: Buy
Price Target: $23
Current: $5.59
Upside: +311.45%
Feb 28, 2022
Maintained: Buy
Price Target: $83 → $114
Current: $348.06
Upside: n/a
Sep 15, 2021
Upgraded: Buy
Price Target: n/a
Current: $17.53
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $123.76
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $98.22
Upside: n/a
Jun 25, 2020
Maintained: Hold
Price Target: n/a
Current: $46.29
Upside: n/a
Dec 16, 2019
Maintained: Buy
Price Target: $18 → $27
Current: $107.13
Upside: n/a
Nov 9, 2018
Downgraded: Hold
Price Target: $18
Current: $0.1745
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $2.69
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $54.09
Upside: n/a
Oct 9, 2018
Initiated Coverage: Buy
Price Target: $35
Current: $30.03
Upside: n/a
May 4, 2017
Reiterated: Buy
Price Target: $19 → $16
Current: $9.02
Upside: n/a
Jan 11, 2017
Maintained: Hold
Price Target: n/a
Current: $2.15
Upside: n/a
May 13, 2014
Maintained: Hold
Price Target: n/a
Current: $3.94
Upside: n/a